Newsroom

Home / Newsroom / Appointment of Dr. Xia Meng as Chief Operating Officer to Lead Commercialization of the Company’s CAR-T and Stem Cell Products
26Jun

Appointment of Dr. Xia Meng as Chief Operating Officer to Lead Commercialization of the Company’s CAR-T and Stem Cell Products

Download Full Article as .PDF (Size: 98 kB)

This CBMG article was posted on 26 Jun 2017